We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Diagnoplex Closes an Extension of its Series A Financing With a Substantial Investment by Debiopharm Group(TM)

News   Jan 19, 2011

 
Diagnoplex Closes an Extension of its Series A Financing With a Substantial Investment by Debiopharm Group(TM)
 
 
 

RELATED ARTICLES

Global Survey Reveals Lack of Ovarian Cancer Awareness

News

Massive global review presents a bleak picture of the challenges faced by women with ovarian cancer, and those who care for them.

READ MORE

Tracking Down Missing-in-Action Multiple Sclerosis Genes

News

Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.

READ MORE

Marker May Help Target Treatments for Crohn’s Patients

News

Accurately predicting which subtype of Crohn's disease is likely to develop has not been possible, until now.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE